Click
on the document icon to open the associated file.
For bilingual papers (s) = Spanish, (e) = English.
All files
are in Adobe Acrobat format.
If you do not have Acrobat, you can download it from here:
|
PUBLISHED
RESEARCH
|
|
Academic science and early industrial research labs in the pharmaceutical industry
with Megan MacGarvie, Journal of Economic Behavior & Organization, 63 (2007) 756–776 [extended version available as NBER Working Paper #11470]. |
|
Public & Private Spillovers, Location, and the Productivity of Pharmaceutical Research
with Margaret K. Kyle, Iain Cockburn, and Rebecca Henderson, Annales d'Economie et de Statistique, forthcoming [also available as NBER Working Paper #12509].
|
|
|
Catching
Up or Standing Still? National Innovative Productivity
among ‘Follower’ Nations, 1978-1999
with Richard Hayes, Research Policy (Dec
2004), 33: 1329-1354. |
|
|
A
Penny For Your Quotes?: The Impact of Biological
Resource Centers on Life Sciences Research
with Scott Stern, Chapter 4 in Biological
Resource Centers: Knowledge Hubs for the Life
Sciences (Scott Stern), 2004, Washington,
DC: Brookings Institution Press.
|
|
|
Location
and Organizing Strategy? Exploring the Influence
of Location on Organization of Pharmaceutical
Research
(2003) in Joel A.C. Baum and Olav Sorenson
(ed.), Advances in Strategic Management,
49-88.
|
|
|
The
Determinants of National Innovative Capacity
with Scott Stern and Michael E. Porter, Research
Policy (2002) 31: 899-933.
|
|
|
Turnarounds
with Anita M. McGahan, Managerial and Decision
Economics (2002) 23: 283-300.
|
|
|
Understanding
the Determinants of National Innovative Capacity
with Scott Stern and Michael E. Porter, Academy
of Management Best Paper Proceedings, 2000
Annual Meeting
|
|
|
Understanding
the Drivers of National Innovative Capacity -
Implications for Central European Economies
with Scott Stern, Wirtschaftspolitische Blätter,
47(2), 2000.
|
|
|
Los
Factores Impulsores de la Capacidad Innovadora
Nacional: Implicaciones para Espana y America
Latina
with Michael E. Porter and Scott Stern, in Claves
de la Economia Mundial (ICEX: Madrid, Spain,
2000), 78-88. [english version, The Drivers of
National Innovative Capacity: Implications for
Spain and Latin America]
|
|
|
RESEARCH
UNDER REVIEW & IN PROGRESS
|
|
|
Climbing
Atop the Shoulders of Giants: The Impact of Institutions
on Cumulative Research
with Scott Stern
|
|
|
Firm Effects vs. Location Effects in the Organization of Pharmaceutical Research
|
|
|
Does industry matter differently in different places? Evidence from four OECD countries
MIT-Sloan working paper #4121.
|
|
|
Local, regional, and national institutional effects and the organization of pharmaceutical research laboratories
|
|
|
The Fragile Foundations of Regional Scientific Advantage? Assessing the Impact of US Stem Cell Policy on the Geography of Scientific Discovery, work in progress.
|
|
|
Entry & Exit in Scientific Competition: The Case of Embryonic Stem Cell Research, 1998-2004
with Fiona Murray, work in progress.
|
|
|
National Regulatory Environments, Firm Characteristics, and Product Entry in the Global Pharmaceutical Industry
with Margaret Kyle, , work in progress.
|
|
|
|
|
(e)
